Universitätsklinikum Eppendorf

Hamburg 20251

1 studies enrolling now · 3 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, GIST, Metastatic Cutaneous Squamous Cell Carcinoma, Primary Hemophagocytic Lymphohistiocytosis

Studies at this site

• A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies — Recruiting now
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer — Running, not enrolling
• Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis — Completed